Provided by Tiger Trade Technology Pte. Ltd.

Cullinan Therapeutics

21.82
+0.14000.65%
Post-market: 21.820.00000.00%19:30 EDT
Volume:617.37K
Turnover:13.50M
Market Cap:1.40B
PE:-6.29
High:22.37
Open:21.62
Low:21.16
Close:21.68
52wk High:22.54
52wk Low:5.68
Shares:64.35M
Float Shares:48.08M
Volume Ratio:0.80
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4680
EPS(LYR):-3.7236
ROE:-50.30%
ROA:-31.36%
PB:4.36
PE(LYR):-5.86

Loading ...

Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 17, 2023

Correspondence

Form CORRESP - Correspondence
Mar 09, 2023

Correspondence

Form CORRESP - Correspondence
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2023

Major Issues Report

8-K - Current report